Withdrawal of synthetic hormones during the perimenopause: A case study

Journal of Psychosomatic Obstetrics and Gynaecology

Volumn 21, Issue 3, 2000, Pages 175-178

  McVeigh, C ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Artificial hormones; Cognitive affective dysfunction; Middle age; Perimenopause

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AFFECTIVE NEUROSIS; ANAMNESIS; ARTICLE; AUSTRALIA; CASE REPORT; CAUCASIAN; COGNITION; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PATIENT MONITORING; WITHDRAWAL SYNDROME;

EID: 0033780876     PISSN: 0167482X     EISSN: None     Source Type: Journal    
DOI: 10.3109/01674820009075625     Document Type: Article

References (28)

1. The perimenopause: A critical time in a woman's life
2. Psychological distress during menopause. Associations across the reproductive life cycle
3. Perimenopausal and postmenopausal hormone replacement therapy
4. The perimenopause and affective disorders
5. Hormones, mood, and cognitive functioning in postmenopausal women
6. Clinical and therapeutic experience during two years at the consultation center: For the study of menopausal and postmenopausal problems
7. Bone-sparing properties of oral contraceptive
8. Reversible contraception for the woman over 35 years of age
9. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer
10. Endometrial cancer and hormone replacement therapy. Appropriate use of progestins to oppose endogenous and exogenous estrogen
11. Hormone replacement therapy, reproductive factors, and cataract. The blue mountains eye study
12. Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women
13. Female menopause, hormone replacement therapy, and cognitive processes
14. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital osteoporosis cooperative research group
15. At what age should oral contraception be stopped?
16. Oral contraceptives for the prevention of osteoporosis
17. Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal women
18. Affective symptoms in women attending a menopause clinic
19. Depression, disability days, and days lost from work in a prospective epidemiologic survey
20. Perimenopause: The transition into menopause
21. New perspectives on the relationship of hormone changes to affective disorders in the perimenopause
22. Psychologic distress during the menopausal years in women attending a menopause clinic
23. Patterns of depressed mood in midlife women: Observations from the Seattle women's health study
24. Mood disorders and menopause
25. Hysterectomy, oophorectomy, and depression in older women
26. Psychoendocrinology of menopause
27. Menopause and healthy ageing. A pilot project